Serum uromodulin (sUmod) represents a promising biomarker for acute kidney injury (AKI) in COVID-19 patients, as reported in a published collaborative study between EUROIMMUN, St Georg Hospital (Leipzig, Germany) and further institutes and clinics. AKI is a frequent complication in patients hospitalized with COVID-19 and is associated with an increased risk of fatal outcomes. Early […]
With passion for rheumatology! Systemic autoimmune rheumatic diseases encompass a wide range of different inflammatory joint, tissue and vascular diseases, such as rheumatoid arthritis, systemic lupus erythematosus and systemic sclerosis. They are diagnosed on the clinical history, imaging techniques, and serological tests. Antibody detection is a useful diagnostic tool and can provide essential information for
SARS-CoV-2, the bird flu A(H7N9), MPox – several new and worrying diseases have appeared over the past years which are a great challenge to public health. In order to protect the population, the responsible health authorities have a range of measures at hand to fight and prevent epidemics. Besides the development of vaccines and medications,
Well prepared for the flu season: diagnostics in the interest of public health At regular intervals, sometimes daily, the latest influenza figures are published. National health authorities around the world collect a variety of patient data. The data are compared with each other or with data from the previous week or from the same time
Myasthenia gravis (MG) is an autoimmune-mediated myasthenic disorder with the main symptom of exertion-related muscle weakness. The disease results from functional loss of the nicotinic acetylcholine receptors (AChR) at the motor end plate due to attacks of different autoantibodies (AAb). Autoantibodies against nicotinic AChR are detected in around 80% of MG patients. AAb against muscle-specific
